Equities

SkinBioTherapeutics PLC

SBTX:LSE

SkinBioTherapeutics PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)10.15
  • Today's Change0.40 / 4.10%
  • Shares traded686.11k
  • 1 Year change-42.00%
  • Beta2.3127
Data delayed at least 20 minutes, as of May 17 2024 16:12 BST.
More ▼
DateOpenHighLowCloseVolume
Friday, May 17, 2024Fri, May 17, 20249.7510.959.5010.15686,106686.11k
Thursday, May 16, 2024Thu, May 16, 20249.7510.859.509.75657,288657.29k
Wednesday, May 15, 2024Wed, May 15, 20248.7510.508.9110.002,841,6382.84m
Tuesday, May 14, 2024Tue, May 14, 20248.608.708.508.60352,648352.65k
Monday, May 13, 2024Mon, May 13, 20248.758.888.508.60167,674167.67k
Friday, May 10, 2024Fri, May 10, 20248.859.008.728.75309,158309.16k
Thursday, May 09, 2024Thu, May 09, 20248.858.888.708.852,881,9322.88m
Wednesday, May 08, 2024Wed, May 08, 20249.259.098.758.85839,245839.25k
Tuesday, May 07, 2024Tue, May 07, 20249.259.259.009.25328,166328.17k
Friday, May 03, 2024Fri, May 03, 20249.259.029.009.2559,29759.30k
Thursday, May 02, 2024Thu, May 02, 20249.259.149.009.25236,233236.23k
Wednesday, May 01, 2024Wed, May 01, 20249.259.149.009.251,064,4551.06m
Tuesday, April 30, 2024Tue, Apr 30, 20249.259.189.009.14142,806142.81k
Monday, April 29, 2024Mon, Apr 29, 20249.259.169.009.25127,560127.56k
Friday, April 26, 2024Fri, Apr 26, 20249.259.189.009.25206,658206.66k
Thursday, April 25, 2024Thu, Apr 25, 20249.259.509.009.2586,02586.03k
Wednesday, April 24, 2024Wed, Apr 24, 20249.259.509.009.25230,111230.11k
Tuesday, April 23, 2024Tue, Apr 23, 20249.259.509.009.25186,038186.04k
Monday, April 22, 2024Mon, Apr 22, 20249.259.469.109.2530,15130.15k
Friday, April 19, 2024Fri, Apr 19, 20249.7510.009.069.2558,26858.27k
Data delayed at least 20 minutes, as of May 17 2024 17:12 BST.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.